🔥 Tuesday 9 June 2026 Tue, 9 June 2026

Zenith Minerals urges shareholders to accept Forrestania Resources’ takeover offer valuing Zenith at a 78.6% premium to its 30-day VWAP, promising access to near-term production and a stronger combined gold portfolio.

Larvotto Resources has secured a binding seven-year gold concentrate offtake agreement with global giant Glencore for its Hillgrove project, complementing an existing antimony deal and paving the way for production in August 2026.

The Supreme Court of Western Australia has approved Genesis Minerals’ acquisition of Magnetic Resources, setting a clear timetable for scheme implementation and ASX trading suspension.

Novo Resources has delivered a maiden inferred resource estimate for the Leven Star Reef within its Belltopper Gold Project, outlining 87,000 ounces of contained gold and setting the stage for further exploration and resource expansion.

Imugene’s off-the-shelf CAR T therapy azer-cel has won FDA Fast Track Designation for relapsed or refractory CLL/SLL and MZL, backed by compelling Phase 1b response rates.

Cadoux Limited has inked a joint venture to earn up to 80% of the Wimmera Mineral Sands Project in Victoria, revealing promising high-grade drilling results at its Danube prospect. The project aims to feed Cadoux’s Minhub processing hub, targeting critical heavy rare earths supply.

Whitefield Income Limited has successfully completed its pro-rata entitlement offer and shortfall offer, raising the maximum A$108 million at A$1.22 per share with demand exceeding supply.

DXN Limited has secured A$7 million from institutional investors to fund delivery of its maiden AI HPC modular data centre contract and expand manufacturing capacity in Southeast Asia.

OncoSil Medical has cleared a major regulatory hurdle as its Humanitarian Device Exemption application nears FDA approval, while its TRIPP-FFX trial shows promising results combining OncoSil with standard chemotherapy for pancreatic cancer.

Elanor Investors Group has finalised a $125 million recapitalisation that slashes its cost of capital and reduces debt, setting the stage for a leaner, capital-light funds management model and imminent ASX reinstatement.

Resonance Health is progressing its MRI Liver Fibrosis device through late-stage clinical validation, targeting FDA biomarker qualification, while maintaining a profitable SaaMD platform and forecasting $16 million revenue for FY26.

PhosCo has uncovered a substantial new phosphate zone at its KH prospect near the Gasaat plant site in Tunisia, confirming thick, shallow mineralisation that could enhance early production economics. Assays are pending ahead of a maiden resource estimate.

Qube Holdings confirms progress on regulatory approvals for its $5.20-per-share takeover scheme by Rubik Australia, with a shareholder meeting scheduled for June 16 and plans for a special dividend.

Aeris Resources continues to hit significant high-grade gold intersections at its Golden Plateau deposit, validating its geological model and setting the stage for a resource update in FY27.

Astron Limited’s updated economic study for Phase 2 of its Donald Rare Earth and Mineral Sands Project reveals a $1.5 billion incremental pre-tax NPV8 and a mine life extended to 52 years, doubling ore throughput and reinforcing the project’s long-term strategic value.

Chariot Resources, through its U.S. subsidiary FMS Lithium Corporation, has significantly expanded its lithium tenure at the Resurgent project in the McDermitt Caldera, staking 573 new claims and nearly doubling its footprint amid improving lithium market conditions.

Horizon Gold has reported multiple high-grade gold intercepts from recent RC drilling at its Gum Creek Project, underpinning resource growth and supporting a mid-2026 feasibility study completion.

Sparc Technologies secures its first international commercial partner as Petro Vietnam Paint commits to using ecosparc® in its PERAPHENE coatings range, targeting highly corrosive environments with improved anticorrosion performance.

Medallion Metals has completed front-end engineering for the Cosmic Boy Concentrator refurbishment and secured a $7.6 million early works contract, keeping commissioning on track for Q2 2027.

American West Metals has struck a significant continuous 108.4m interval of high-grade indium mineralisation at its West Desert Project, expanding the known resource and confirming a large-scale skarn system with zinc, gold, silver, and copper by-products.

Alterity Therapeutics has clinched FDA agreement on the pivotal Phase 3 trial design for ATH434, targeting Multiple System Atrophy, with the trial set to begin by the end of 2026.

Carnaby Resources has solidified its Miniboom Lode discovery with wide, high-grade copper-gold intersections near Mount Hope Central and extended the Trek 1 mineralisation with substantial new drill results, underpinning its mid-year feasibility study and 2026 production target.

Forrestania Resources has launched a recommended off-market takeover bid for Zenith Minerals, valuing Zenith at about A$93.5 million with a 46.7% premium. The deal aims to create a larger, diversified Western Australian gold explorer and developer.

Kuniko Limited is set to kick off Phase 2 diamond drilling at its Commonwealth–Silica Hill Project in early July 2026, aiming to extend mineralisation and deliver a resource upgrade by year-end. The move follows a successful Phase 1 campaign that intersected mineralisation in all holes and unveiled a significant new zone at Silica Hill.